Sickle Cell Disease Market Insight, Epidemiology And Market Forecast - 2034The sickle cell disease treatment market is experiencing signific ...

Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. Pfizer's dismal stock performance in recent years underscores the challenges the big drugmaker faces.

This setback is particularly troubling since Pfizer invested $5.4 billion to acquire Global Blood Therapeutics, the developer of Oxbryta. Analysts have criticized Pfizer for potentially overpaying ...

In addition to Pfizer, the complaint named California-based Global Blood Therapeutics, the company that discovered and developed the drug. The Food and Drug Administration approved Oxbryta in 2019.

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a panel discussion among sickle cell experts Saturday at STAT@ASH, ...

Pfizer’s abrupt withdrawal of sickle cell drug Oxbryta called ‘tone deaf’ at ASH conference Experts said patients were despondent over how suddenly the drug was pulled from the market ...

Campaign: Sickle Cell SpeaksAgency/Firm: Riester RxClient: Pfizer (Oxbryta) When Pfizer acquired Global Blood Therapeutics in October 2022, the flagship drug in the company’s portfolio was ...

While the recall of the sickle cell drug Oxbryta certainly doesn’t improve Pfizer’s business development track record, we think management is executing on track with its $4 billion cost ...

Risks to consider Pfizer faces risks that investors should consider. The company took on significant debt to fund the Seagen acquisition, evidenced by its debt-to-equity ratio of 0.78.

After Pfizer’s coronavirus vaccine success, CEO targeted for revenue slump A big shareholder, Starboard Value, has alleged Pfizer interfered in its efforts to drive change by working with two ...

In September, Pfizer said it was voluntarily withdrawing Oxbryta, a treatment for sickle cell disease approved in 2019 by the Food and Drug Administration that it acquired in its $5.4 billion ...